Ayumi Watanabe

1.1k total citations
38 papers, 330 citations indexed

About

Ayumi Watanabe is a scholar working on Oncology, Immunology and Epidemiology. According to data from OpenAlex, Ayumi Watanabe has authored 38 papers receiving a total of 330 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 15 papers in Immunology and 13 papers in Epidemiology. Recurrent topics in Ayumi Watanabe's work include CAR-T cell therapy research (12 papers), Cytomegalovirus and herpesvirus research (8 papers) and Immunotherapy and Immune Responses (7 papers). Ayumi Watanabe is often cited by papers focused on CAR-T cell therapy research (12 papers), Cytomegalovirus and herpesvirus research (8 papers) and Immunotherapy and Immune Responses (7 papers). Ayumi Watanabe collaborates with scholars based in United States, Japan and Greece. Ayumi Watanabe's co-authors include Takeshi Sunanaga, Kazuo Kawamura, Hiroshi Toyama, Manik Kuvalekar, Ann M. Leen, Spyridoula Vasileiou, Premal Lulla, Ifigeneia Tzannou, Kazue Higuchi and Swati Naik and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Ayumi Watanabe

33 papers receiving 328 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ayumi Watanabe United States 11 107 92 78 60 55 38 330
Suchin Worawichawong Thailand 13 66 0.6× 50 0.5× 79 1.0× 42 0.7× 49 0.9× 47 464
Douglas Schneider United States 10 67 0.6× 76 0.8× 33 0.4× 56 0.9× 49 0.9× 24 388
Ryota Tanaka Japan 14 76 0.7× 144 1.6× 29 0.4× 45 0.8× 158 2.9× 46 479
Cristián Vera‐Kellet Chile 11 52 0.5× 118 1.3× 36 0.5× 21 0.3× 23 0.4× 53 386
Miwa Morikawa Japan 12 87 0.8× 80 0.9× 27 0.3× 101 1.7× 226 4.1× 39 465
Yunying Zhou China 9 37 0.3× 71 0.8× 30 0.4× 96 1.6× 52 0.9× 21 394
Antoine Roux France 11 41 0.4× 119 1.3× 165 2.1× 42 0.7× 36 0.7× 23 381
Hakan Koç Türkiye 10 96 0.9× 75 0.8× 66 0.8× 23 0.4× 24 0.4× 38 369
R. D. Wilkinson United Kingdom 13 104 1.0× 53 0.6× 85 1.1× 18 0.3× 28 0.5× 22 398

Countries citing papers authored by Ayumi Watanabe

Since Specialization
Citations

This map shows the geographic impact of Ayumi Watanabe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ayumi Watanabe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ayumi Watanabe more than expected).

Fields of papers citing papers by Ayumi Watanabe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ayumi Watanabe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ayumi Watanabe. The network helps show where Ayumi Watanabe may publish in the future.

Co-authorship network of co-authors of Ayumi Watanabe

This figure shows the co-authorship network connecting the top 25 collaborators of Ayumi Watanabe. A scholar is included among the top collaborators of Ayumi Watanabe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ayumi Watanabe. Ayumi Watanabe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vasileiou, Spyridoula, et al.. (2024). Phenotypic and Functional Characterization of Posoleucel, a Multivirus-Specific T Cell Therapy for the Treatment and Prevention of Viral Infections in Immunocompromised Patients. Transplantation and Cellular Therapy. 30(2). S427–S428. 1 indexed citations
2.
Shafer, Paul, Maksim Mamonkin, LaQuisa Hill, et al.. (2024). Targeting IDH2R140Q and other neoantigens in acute myeloid leukemia. Blood. 143(17). 1726–1737. 9 indexed citations
4.
Kuvalekar, Manik, et al.. (2023). T cell immune profiling of respiratory syncytial virus for the development of a targeted immunotherapy. British Journal of Haematology. 202(4). 874–878. 6 indexed citations
5.
Jones, Julia, Manik Kuvalekar, Ayumi Watanabe, et al.. (2023). Assessment of the cytolytic potential of a multivirus-targeted T cell therapy using a vital dye-based, flow cytometric assay. Frontiers in Immunology. 14. 1299512–1299512. 3 indexed citations
7.
Vasileiou, Spyridoula, LaQuisa Hill, Manik Kuvalekar, et al.. (2022). Allogeneic, off-the-shelf, SARS-CoV-2-specific T cells (ALVR109) for the treatment of COVID-19 in high-risk patients. Haematologica. 108(7). 1840–1850. 16 indexed citations
8.
Vasileiou, Spyridoula, Manik Kuvalekar, Ayumi Watanabe, et al.. (2021). Allogeneic, Off-the-Shelf, Sars-Cov-2-Specific T Cells to Treat High-Risk Patients with COVID-19. Transplantation and Cellular Therapy. 27(3). S348–S349. 3 indexed citations
10.
Ohno, Yoshiharu, Daisuke Takenaka, Takeshi Yoshikawa, et al.. (2021). Efficacy of Ultrashort Echo Time Pulmonary MRI for Lung Nodule Detection and Lung-RADS Classification. Radiology. 302(3). 697–706. 27 indexed citations
12.
Kawai, Hideki, Masayoshi Sarai, Yasuchika Kato, et al.. (2020). Diagnosis of Isolated Cardiac Sarcoidosis Based on New Guidelines. ESC Heart Failure. 7(5). 2662–2671. 29 indexed citations
13.
Nagata, Hiroyuki, Kazuhiro Murayama, Shigetaka Suzuki, et al.. (2019). Initial clinical experience of a prototype ultra-high-resolution CT for assessment of small intracranial arteries. Japanese Journal of Radiology. 37(4). 283–291. 14 indexed citations
14.
Vasileiou, Spyridoula, Manik Kuvalekar, Ayumi Watanabe, et al.. (2019). Rapid generation of multivirus-specific T lymphocytes for the prevention and treatment of respiratory viral infections. Haematologica. 105(1). 235–243. 27 indexed citations
15.
Vasileiou, Spyridoula, Manik Kuvalekar, Ayumi Watanabe, et al.. (2019). Rapid Generation of Multivirus-Specific T Lymphocytes for the Prevention and Treatment of Respiratory Viral Infections. Biology of Blood and Marrow Transplantation. 25(3). S363–S363. 4 indexed citations
16.
Lulla, Premal, Swati Naik, Ifigeneia Tzannou, et al.. (2017). Safety and Efficacy of Adoptively Transferred Donor-Derived Tumor-Directed T Cells with Relapsed AML Post-Allogeneic HSCT. Blood. 130. 164–164. 1 indexed citations
17.
Li, Xiuli, Kazuhiro Murayama, Ayumi Watanabe, Masato Abe, & Hiroshi Toyama. (2016). Primary Intracranial Choriocarcinoma Located in the Suprasellar Region. PubMed. 10(1). 80–84.
18.
Inoue, Hiroyuki, Chika Sakamoto, Yumiko Matsumura, et al.. (2014). TLR7 Ligand Augments GM-CSF–Initiated Antitumor Immunity through Activation of Plasmacytoid Dendritic Cells. Cancer Immunology Research. 2(6). 568–580. 15 indexed citations
19.
Higuchi, Kazue, Yukie Sekiya, Hidetoshi Igari, Ayumi Watanabe, & Nobuyuki Harada. (2012). Comparison of specificities between two interferon-gamma release assays in Japan [Short communication]. The International Journal of Tuberculosis and Lung Disease. 16(9). 1190–1192. 27 indexed citations
20.
Sunanaga, Takeshi, Ayumi Watanabe, & Kazuo Kawamura. (2006). Involvement of vasa homolog in germline recruitment from coelomic stem cells in budding tunicates. Development Genes and Evolution. 217(1). 1–11. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026